Inventor · disambiguated record
Alexander M. Klibanov
Also filed as: KLIBANOV ALEXANDER · KLIBANOV ALEXANDER M
42 granted patents·21 pending applications·1,897 citations·filing 1981–2025
98Inventor score
Files withCOLLEGIUM PHARMACEUTICAL INC14EAGLE BIOLOGICS INC14MASSACHUSETTS INST TECHNOLOGY14CAMBRIDGE SCIENT INC4INNOVATIVE SCIENT PRODUCTS INC3
Top patents by PatentIndex Score
63 records- 0198US7771707B2Abuse-deterrent drug formulationsCOLLEGIUM PHARMACEUTICAL INC·Filed 2005·Granted Aug 10, 2010·62 cites·30 claims
- 0298US6174952B1Monolithic polymer composition having a water absorption materialCAPITOL SPECIALTY PLASTICS INC·Filed 1998·Granted Jan 16, 2001·118 cites·24 claims
- 0397US12109173B1Pharmaceutical container with pH protective layer deposited by atomic layer depositionINNOVATIVE SCIENT PRODUCTS INC·Filed 2024·Granted Oct 8, 2024·4 cites·30 claims
- 0497US6241771B1Resorbable interbody spinal fusion devicesCAMBRIDGE SCIENT INC·Filed 1998·Granted Jun 5, 2001·814 cites·7 claims
- 0596US8557291B2Abuse-deterrent pharmaceutical compositions of opioids and other drugsRARIY ROMAN V·Filed 2009·Granted Oct 15, 2013·29 cites·19 claims
- 0696US4414147AMethods of decreasing the hydrophobicity of fibroblast and other interferonsMASSACHUSETTS INST TECHNOLOGY·Filed 1981·Granted Nov 8, 1983·186 cites·3 claims
- 0795US9248195B2Abuse-deterrent pharmaceutical compositions of opioids and other drugsCOLLEGIUM PHARMACEUTICAL INC·Filed 2013·Granted Feb 2, 2016·15 cites·22 claims
- 0895US8758813B2Abuse-deterrent drug formulationsCOLLEGIUM PHARMACEUTICAL INC·Filed 2013·Granted Jun 24, 2014·20 cites·20 claims
- 0994US9592200B2Abuse-deterrent pharmaceutical compositions of opioids and other drugsCOLLEGIUM PHARMACEUTICAL INC·Filed 2015·Granted Mar 14, 2017·10 cites·22 claims
- 1094US9044398B2Abuse-deterrent pharmaceutical compositions of opiods and other drugsHIRSH JANE·Filed 2012·Granted Jun 2, 2015·26 cites·11 claims
- 1191US12303461B1Pharmaceutical container with pH protective layer deposited by atomic layer depositionINNOVATIVE SCIENT PRODUCTS INC·Filed 2024·Granted May 20, 2025·0 cites·26 claims
- 1291US9763883B2Abuse-deterrent drug formulationsCOLLEGIUM PHARMACEUTICAL INC·Filed 2014·Granted Sep 19, 2017·9 cites·20 claims
- 1390US2024181063A1Liquid Protein Formulations Containing Viscosity-Lowering AgentsEAGLE BIOLOGICS INC·Filed 2024·Application pending·0 cites
- 1490US2024285766A1Liquid Protein Formulations Containing Ionic LiquidsEAGLE BIOLOGICS INC·Filed 2024·Application pending·0 cites
- 1589US10849977B2Liquid Protein Formulations Containing ThiamineEAGLE BIOLOGICS INC·Filed 2018·Granted Dec 1, 2020·2 cites·20 claims
- 1689US10821184B2Liquid protein formulations containing thiamine pyrophosphate (TPP)EAGLE BIOLOGICS INC·Filed 2018·Granted Nov 3, 2020·2 cites·22 claims
- 1789US7151139B2Antimicrobial polymeric surfacesTUFTS COLLEGE·Filed 2002·Granted Dec 19, 2006·67 cites·20 claims
- 1888US10500317B2Antibacterial coatings that inhibit biofilm formation on implantsMASSACHUSETTS INST TECHNOLOGY·Filed 2017·Granted Dec 10, 2019·4 cites·20 claims
- 1988US6548002B2Method of making a biodegradable interbody spinal fusion devicesCAMBRIDGE SCIENT INC·Filed 2001·Granted Apr 15, 2003·126 cites·2 claims
- 2087US11471479B2Polysaccharide and nucleic acid formulations containing viscosity-lowering agentsEAGLE BIOLOGICS INC·Filed 2015·Granted Oct 18, 2022·3 cites·32 claims
- 2187US10646571B2Liquid protein formulations containing cimetidineEAGLE BIOLOGICS INC·Filed 2018·Granted May 12, 2020·1 cites·20 claims
- 2287US9913905B2Liquid pharmaceutical formulations for injection comprising thiamine pyrophosphate 1-(3-aminopropyl)-2-methyl-1H-imidazole and uses thereofEAGLE BIOLOGICS INC·Filed 2014·Granted Mar 13, 2018·5 cites·25 claims
- 2386US9833513B2Liquid protein formulations for injection comprising 1-butyl-3-methylimidazolium methanesulfonate and uses thereofEAGLE BIOLOGICS INC·Filed 2014·Granted Dec 5, 2017·4 cites·26 claims
- 2486US4623465ARemoval of combined organic substances from aqueous solutionsMASSACHUSETTS INST TECHNOLOGY·Filed 1985·Granted Nov 18, 1986·55 cites·11 claims
- 2585US10525052B2Abuse-deterrent drug formulationsCOLLEGIUM PHARMACEUTICAL INC·Filed 2017·Granted Jan 7, 2020·2 cites·14 claims
- 2685US10525053B2Abuse-deterrent pharmaceutical compositions of opioids and other drugsCOLLEGIUM PHARMACEUTICAL INC·Filed 2017·Granted Jan 7, 2020·2 cites·12 claims
- 2784US9925263B2Liquid pharmaceutical formulations for injection comprising procaine and uses thereofEAGLE BIOLOGICS INC·Filed 2014·Granted Mar 27, 2018·3 cites·24 claims
- 2883US4601987AEnzymatic production of optical isomers of 2-halopropionic acidsMASSACHUSETTS INST TECHNOLOGY·Filed 1985·Granted Jul 22, 1986·27 cites·17 claims
- 2981US2020093819A1Abuse-deterrent drug formulationsCOLLEGIUM PHARMACEUTICAL INC·Filed 2019·Application pending·0 cites
- 3080US9089407B2Antibacterial coatings that inhibit biofilm formation on implantsMASSACHUSETTS INST TECHNOLOGY·Filed 2012·Granted Jul 28, 2015·4 cites·22 claims
- 3179US12447107B2Pharmaceutical container with pH protective layer deposited by atomic layer depositionINNOVATIVE SCIENT PRODUCTS INC·Filed 2025·Granted Oct 21, 2025·0 cites·22 claims
- 3277US11986526B2Liquid protein formulations containing 4-ethyl-4-methylmorpholinium methylcarbonate (EMMC)EAGLE BIOLOGICS INC·Filed 2020·Granted May 21, 2024·0 cites·24 claims
- 3377US11819550B2Liquid protein formulations containing cyclic adenosine monophosphate (cAMP) or adenosine triphosphate (ATP)EAGLE BIOLOGICS INC·Filed 2020·Granted Nov 21, 2023·0 cites·28 claims
- 3477US10179172B2Liquid pharmaceutical formulations for injection comprising yellow 5 or orange G and uses thereofEAGLE BIOLOGICS INC·Filed 2014·Granted Jan 15, 2019·1 cites·27 claims
- 3577US6660715B2Nonaqueous solutions and suspensions of macromolecules for pulmonary deliveryMASSACHUSETTS INST TECHNOLOGY·Filed 1999·Granted Dec 9, 2003·43 cites·11 claims
- 3677US2021085792A1Liquid Protein Formulations Containing Viscosity-Lowering AgentsEAGLE BIOLOGICS INC·Filed 2020·Application pending·0 cites
- 3775US9731026B2Neat liquid pharmaceutical formulationsMASSACHUSETTS INST TECHNOLOGY·Filed 2015·Granted Aug 15, 2017·2 cites·20 claims
- 3873US7077866B2Resorbable interbody spinal fusion devicesDEPUY MITEK INC·Filed 2001·Granted Jul 18, 2006·39 cites·24 claims
- 3972US2020345723A1Abuse-deterrent pharmaceutical compositions of opioids and other drugsCOLLEGIUM PHARMACEUTICAL INC·Filed 2020·Application pending·0 cites
- 4072US2020345722A1Abuse-deterrent drug formulationsCOLLEGIUM PHARMACEUTICAL INC·Filed 2020·Application pending·0 cites
- 4171US2020093820A1Abuse-deterrent pharmaceutical compositions of opioids and other drugsCOLLEGIUM PHARMACEUTICAL INC·Filed 2019·Application pending·0 cites
- 4270US10821183B2Liquid protein formulations containing 4-(3-butyl-1-imidazolio)-1-butane sulfonate (BIM)EAGLE BIOLOGICS INC·Filed 2017·Granted Nov 3, 2020·0 cites·23 claims
- 4369US5547833ARadial flow assay, delivering member, test kit, and methodsINTRACEL CORP·Filed 1994·Granted Aug 20, 1996·35 cites·6 claims
- 4467US2017182032A1Abuse-deterrent pharmaceutical compositions of opioids and other drugsCOLLEGIUM PHARMACEUTICAL INC·Filed 2017·Application pending·0 cites
- 4566US2008260819A1Sustained release compositions of drugsCOLLEGIUM PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 4663US4826762AEnzymatic temperature change indicatorMASSACHUSETTS INDUSTRY OF TECH·Filed 1987·Granted May 2, 1989·25 cites·8 claims
- 4763US2018028528A1Abuse-deterrent pharmaceutical compositions of opioids and other drugsCOLLEGIUM PHARMACEUTICAL INC·Filed 2017·Application pending·0 cites
- 4862US5618539AStabilized vaccine compositionsMASSACHUSETTS INST TECHNOLOGY·Filed 1994·Granted Apr 8, 1997·23 cites·32 claims
- 4961US2024341300A1Preservative composition for nucleic acids and biological samples and methods of useSIO2 MEDICAL PRODUCTS INC·Filed 2022·Application pending·0 cites
- 5060US5817328AMaterial for buffered resorbable internal fixation devices and method for making sameCAMBRIDGE SCIENT INC·Filed 1996·Granted Oct 6, 1998·47 cites·61 claims
Showing the top 50 of 63 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →